New FDA-Approved Treatment for RKD

The FDA has approved Gazyva® (obinutuzumab) for adults and children ages 2 and older with idiopathic nephrotic syndrome that began in childhood and is frequently relapsing (FRNS) or steroid-dependent (SDNS). More information coming soon. Please visit our Patient Navigation tool for support.

RESOURCES

/

FIND A SPECIALIST

/

CONTACT

HOME / SEARCH RESULTS

Search Results

Topics

disease type

Resources

Showing 1-3 of 5 results for:

NephCure Celebrates C3G Awareness Day on September 25, 2026

NephCure, a leading nonprofit organization advocating to ensure that all individuals with rare, protein-spilling kidney disease have equitable access to the care and treatments that offer them the best kidney health outcome ... Read more

NephCure Specialist of the Month: Dr. Rupali Avasare

We are extremely proud to highlight Dr. Rupali Avasare as our NephCure Specialist of the month for September. This initiative recognizes the outstanding contributions of  NephCure Specialists to the field of nephrology and spotlights their ... Read more

Making History on Capitol Hill: Record Advocates Unite for NephCure’s Largest Hill Day Ever

NephCure is a leading patient advocacy organization advocating to ensure that all individuals with rare, protein-spilling kidney disease have equitable access to the care and treatments that offer them the best kidney health outcome ... Read more

Sign up to get NephCure’s latest updates.

SIGN UP
This field is for validation purposes and should be left unchanged.